Orally Available Small Molecule Inhibitor of SCD1 Targets Mesothelioma Metabolism, Study Finds
News
New preclinical research shows that T-3764518, an orally available small molecule inhibitor of stearoyl-CoA desaturate-1 (SCD1), can block tumor growth in colon cancer and mesothelioma cell lines as well as ... Read more